110 related articles for article (PubMed ID: 11559357)
1. All or none fibrillogenesis of a prion peptide.
Zou WQ; Yang DS; Fraser PE; Cashman NR; Chakrabartty A
Eur J Biochem; 2001 Sep; 268(18):4885-91. PubMed ID: 11559357
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
3. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
[TBL] [Abstract][Full Text] [Related]
4. DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid.
Nandi PK; Leclerc E; Nicole JC; Takahashi M
J Mol Biol; 2002 Sep; 322(1):153-61. PubMed ID: 12215421
[TBL] [Abstract][Full Text] [Related]
5. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
7. Contribution of specific residues of the β-solenoid fold to HET-s prion function, amyloid structure and stability.
Daskalov A; Gantner M; Wälti MA; Schmidlin T; Chi CN; Wasmer C; Schütz A; Ceschin J; Clavé C; Cescau S; Meier B; Riek R; Saupe SJ
PLoS Pathog; 2014 Jun; 10(6):e1004158. PubMed ID: 24945274
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
9. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
Satheeshkumar KS; Murali J; Jayakumar R
J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
[TBL] [Abstract][Full Text] [Related]
10. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
11. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
LeVine H
Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
[TBL] [Abstract][Full Text] [Related]
12. The peculiar nature of unfolding of the human prion protein.
Baskakov IV; Legname G; Gryczynski Z; Prusiner SB
Protein Sci; 2004 Mar; 13(3):586-95. PubMed ID: 14767078
[TBL] [Abstract][Full Text] [Related]
13. Defining the pathway of worm-like amyloid fibril formation by the mouse prion protein by delineation of the productive and unproductive oligomerization reactions.
Jain S; Udgaonkar JB
Biochemistry; 2011 Feb; 50(7):1153-61. PubMed ID: 21214263
[TBL] [Abstract][Full Text] [Related]
14. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
[TBL] [Abstract][Full Text] [Related]
15. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
Wildegger G; Liemann S; Glockshuber R
Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
[TBL] [Abstract][Full Text] [Related]
16. Computer simulation study of amyloid fibril formation by palindromic sequences in prion peptides.
Wagoner VA; Cheon M; Chang I; Hall CK
Proteins; 2011 Jul; 79(7):2132-45. PubMed ID: 21557317
[TBL] [Abstract][Full Text] [Related]
17. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R
J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
Selvaggini C; De Gioia L; Cantù L; Ghibaudi E; Diomede L; Passerini F; Forloni G; Bugiani O; Tagliavini F; Salmona M
Biochem Biophys Res Commun; 1993 Aug; 194(3):1380-6. PubMed ID: 8102526
[TBL] [Abstract][Full Text] [Related]
19. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
20. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
